Infection of human endothelial cells by human T-cell leukemia virus type I.

Por Hoxie, J A, Matthews, D M, Cines, D B
Publicado em 1984

Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.

Por Bennett, J S, Hoxie, J A, Leitman, S F, Vilaire, G, Cines, D B
Publicado em 1983

Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses.

Por Inoue, M, Hoxie, J A, Reddy, M V, Srinivasan, A, Reddy, E P
Publicado em 1991

Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1.

Por Bandyopadhyay, S, Ziegner, U, Campbell, D E, Miller, D S, Hoxie, J A, Starr, S E
Publicado em 1990

Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.

Por Hoxie, J A, Brass, L F, Pletcher, C H, Haggarty, B S, Hahn, B H
Publicado em 1991

Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection.

Por Hoxie, J A, Haggarty, B S, Bonser, S E, Rackowski, J L, Shan, H, Kanki, P J
Publicado em 1988

CD4-independent infection of human neural cells by human immunodeficiency virus type 1.

Por Harouse, J M, Kunsch, C, Hartle, H T, Laughlin, M A, Hoxie, J A, Wigdahl, B, Gonzalez-Scarano, F
Publicado em 1989

Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.

Por Richardson, T M, Stryjewski, B L, Broder, C C, Hoxie, J A, Mascola, J R, Earl, P L, Doms, R W
Publicado em 1996

Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent.

Por McKnight, A, Wilkinson, D, Simmons, G, Talbot, S, Picard, L, Ahuja, M, Marsh, M, Hoxie, J A, Clapham, P R
Publicado em 1997

Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.

Por Hahn, B H, Gonda, M A, Shaw, G M, Popovic, M, Hoxie, J A, Gallo, R C, Wong-Staal, F
Publicado em 1985

Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.

Por Kumar, P, Hui, H X, Kappes, J C, Haggarty, B S, Hoxie, J A, Arya, S K, Shaw, G M, Hahn, B H
Publicado em 1990

Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus.

Por LaBranche, C C, Sauter, M M, Haggarty, B S, Vance, P J, Romano, J, Hart, T K, Bugelski, P J, Hoxie, J A
Publicado em 1994

Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus.

Por LaBranche, C C, Sauter, M M, Haggarty, B S, Vance, P J, Romano, J, Hart, T K, Bugelski, P J, Hoxie, J A
Publicado em 1994

The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemias.

Por Huebner, K, Isobe, M, Chao, M, Bothwell, M, Ross, A H, Finan, J, Hoxie, J A, Sehgal, A, Buck, C R, Lanahan, A
Publicado em 1986

CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons.

Por Lavi, E., Strizki, J. M., Ulrich, A. M., Zhang, W., Fu, L., Wang, Q., O'Connor, M., Hoxie, J. A., González-Scarano, F.
Publicado em 1997

A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells.

Por LaBranche, C C, Sauter, M M, Haggarty, B S, Vance, P J, Romano, J, Hart, T K, Bugelski, P J, Marsh, M, Hoxie, J A
Publicado em 1995

Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein.

Por Bron, R, Klasse, P J, Wilkinson, D, Clapham, P R, Pelchen-Matthews, A, Power, C, Wells, T N, Kim, J, Peiper, S C, Hoxie, J A, Marsh, M
Publicado em 1997

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

Por Bar, K.J., Sneller, M.C., Harrison, L.J., Justement, J.S., Overton, E.T., Petrone, M.E., Salantes, D.B., Seamon, C.A., Scheinfeld, B., Kwan, R.W., Learn, G.H., Proschan, M.A., Kreider, E.F., Blazkova, J., Bardsley, M., Refsland, E.W., Messer, M., Clarridge, K.E., Tustin, N.B., Madden, P.J., Oden, K.S., O’Dell, S.J., Jarocki, B., Shiakolas, A.R., Tressler, R.L., Doria-Rose, N.A., Bailer, R.T., Ledgerwood, J.E., Capparelli, E.V., Lynch, R.M., Graham, B.S., Moir, S., Koup, R.A., Mascola, J.R., Hoxie, J.A., Fauci, A.S., Tebas, P., Chun, T.-W.
Publicado no N Engl J Med (2016)